Ej. Popke et al., Differential effects of two NMDA receptor antagonists on cognitive-behavioral development in nonhuman primates, NEUROTOX T, 23(4), 2001, pp. 319-332
The present experiment examined effects of chronic exposure to remacemide (
an N-methyl-D-aspartate [NMDA] antagonist which also blocks fast sodium cha
nnels) or MK-801 (which blocks NMDA receptors, exclusively) on teaming and
motivation in young rhesus monkeys. Remacemide (20 or 50 mg/kg/day) or MK-8
01 (0.1 or 1.0 mg/kg/day) was administered every day to separate groups of
animals via orogastric gavage for up to 2 years. Immediately prior to dosin
g, 5 days per week (M-F), throughout the 2-year dosing period, an increment
al repeated acquisition (IRA) task was used to assess learning and a progre
ssive ratio (PR) task was used to assess motivation. The results indicate a
n effect of 50 mg/kg/day remacemide to impair learning (IRA) which persiste
d even after drug treatment was discontinued. MK-801 had no effect on teami
ng but transiently increased motivation. Because the effects of remacemide
occurred independently of changes in motivation or response rates, they are
likely due to specific cognitive impairments and are not due to an inabili
ty of subjects to fulfill the motoric requirements of the task. The fact th
at MK-801 did not alter learning suggests that NMDA antagonism alone may be
insufficient to produce learning deficits in young monkeys and that such d
eficits may rely on the ancillary blockade of fast sodium channels. (C) 200
1 Elsevier Science Inc. All rights reserved.